Page 3 - Decision Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Who Needs to Know Why It Matters As evidenced in the recently published 2020 Year in Review Report (Report), the Department of Justice’s Fraud Section (Fraud Section) demonstrated its resilience despite the COVID-19 pandemic, as well as its swift response to the evolution of pandemic-induced fraud — a trend we expect will continue throughout 2021. As evidenced in the recently published 2020 Year in Review Report (Report), the Department of Justice’s Fraud Section (Fraud Section) demonstrated its resilience despite the COVID-19 pandemic, as well as its swift response to the evolution of ...

Press release content from NewMediaWire. The AP news staff was not involved in its creation. DECISION DIAGNOSTICS CLASS ACTION REMINDER Faruqi & Faruqi LLPFebruary 28, 2021 GMT Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options NEW YORK, NY - ( NewMediaWire ) - February 28, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Decision Diagnostics Corp. (“Decision Diagnostics” or the “Company”...

Press release content from NewMediaWire. The AP news staff was not involved in its creation. DECISION DIAGNOSTICS SHAREHOLDER NOTICE Faruqi & Faruqi LLPFebruary 27, 2021 GMT Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options NEW YORK, NY - ( NewMediaWire ) - February 27, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Decision Diagnostics Corp. (“Decision Diagnostics” or the “Company”) (...

Share this article Share this article NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Decision Diagnostics Corporation ("Decision Diagnostics" or the "Company") (OTCMKTS: DECN) and certain of its officers. The class action, filed in United States District Court for the Central District of California, and docketed under 21-cv-00418, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Decision Diagnostics securities between March 3, 2020 and December 17, 2020...

Decision Diagnostics Shareholder Notice Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options